Literature DB >> 17876892

Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function.

Jurgen Bock1, Gerhard Liebisch, Joachim Schweimer, Gerd Schmitz, Gerhard Rogler.   

Abstract

AIM: To test the hypothesis that hydrolysis of sphingomyelin to ceramide changes the composition of tight junctions (TJs) with increasing permeability of the intestinal epithelium.
METHODS: Monolayers of Caco-2 cells were used as an in vitro model for the intestinal barrier. Permeability was determined by quantification of transepithelial flux and transepithelial resistance. Sphingolipid-rich membrane microdomains were isolated by a discontinuous sucrose gradient and characterized by Western-blot. Lipid content of microdomains was analysed by tandem mass spectrometry. Ceramide was subcellularly localized by immunofluorescent staining.
RESULTS: Exogenous sphingomyelinase increased transepithelial permeability and decreased transepithelial resistance at concentrations as low as 0.01 U/mL. Lipid analysis showed rapid accumulation of ceramide in the membrane fractions containing occludin and claudin-4, representing TJs. In these fractions we observed a concomitant decrease of sphingomyelin and cholesterol with increasing concentrations of ceramide. Immunofluorescent staining confirmed clustering of ceramide at the sites of cell-cell contacts. Neutralization of surface ceramide prevented the permeability-increase induced by platelet activating factor.
CONCLUSION: Our findings indicate that changes in lipid composition of TJs impair epithelial barrier functions. Generation of ceramide by sphingomyelinases might contribute to disturbed barrier function seen in diseases such as inflammatory, infectious, toxic or radiogenic bowel disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876892      PMCID: PMC4171303          DOI: 10.3748/wjg.v13.i39.5217

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  44 in total

1.  Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis.

Authors:  W Stremmel; U Merle; A Zahn; F Autschbach; U Hinz; R Ehehalt
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

2.  Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms.

Authors:  Heike Grassmé; Andrea Riehle; Barbara Wilker; Erich Gulbins
Journal:  J Biol Chem       Date:  2005-05-10       Impact factor: 5.157

3.  High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm.

Authors:  Gerhard Liebisch; Bernd Lieser; Jan Rathenberg; Wolfgang Drobnik; Gerd Schmitz
Journal:  Biochim Biophys Acta       Date:  2004-11-08

4.  Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells.

Authors:  H Grassmé; E Gulbins; B Brenner; K Ferlinz; K Sandhoff; K Harzer; F Lang; T F Meyer
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

5.  Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry.

Authors:  B Brügger; G Erben; R Sandhoff; F T Wieland; W D Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

Authors:  M Y Kim; C Linardic; L Obeid; Y Hannun
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

Review 7.  Raft ceramide in molecular medicine.

Authors:  Erich Gulbins; Richard Kolesnick
Journal:  Oncogene       Date:  2003-10-13       Impact factor: 9.867

8.  Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Authors:  Monica Garcia-Barros; Francois Paris; Carlos Cordon-Cardo; David Lyden; Shahin Rafii; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

9.  Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease.

Authors:  R Shoda; K Matsueda; S Yamato; N Umeda
Journal:  J Gastroenterol       Date:  1995-11       Impact factor: 7.527

10.  Tight junctions are membrane microdomains.

Authors:  A Nusrat; C A Parkos; P Verkade; C S Foley; T W Liang; W Innis-Whitehouse; K K Eastburn; J L Madara
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  19 in total

Review 1.  Ceramide signaling in the gut.

Authors:  Ying Li; Rebekah J Nicholson; Scott A Summers
Journal:  Mol Cell Endocrinol       Date:  2022-01-05       Impact factor: 4.102

2.  Fecal sphingolipids predict parenteral nutrition-associated cholestasis in the neonatal intensive care unit.

Authors:  Thomas J Moutinho; Deborah A Powers; Gabriel F Hanson; Shira Levy; Rajiv Baveja; Isabel Hefner; Masouma Mohamed; Alaa Abdelghani; Robin L Baker; Jason A Papin; Sean R Moore; Suchitra K Hourigan
Journal:  JPEN J Parenter Enteral Nutr       Date:  2022-03-13       Impact factor: 3.896

3.  Expression of alkaline sphingomyelinase in yeast cells and anti-inflammatory effects of the expressed enzyme in a rat colitis model.

Authors:  David Andersson; Knut Kotarsky; Jun Wu; William Agace; Rui-Dong Duan
Journal:  Dig Dis Sci       Date:  2008-11-07       Impact factor: 3.199

4.  Intestinal barrier function is modulated by short-term exposure to fumonisin B₁ in Ussing chambers.

Authors:  Jean-Paul Lallès; Martin Lessard; Gaëlle Boudry
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

5.  Histo-blood group antigens of glycosphingolipids predict susceptibility of human intestinal enteroids to norovirus infection.

Authors:  Inga Rimkute; Konrad Thorsteinsson; Marcus Henricsson; Victoria R Tenge; Xiaoming Yu; Shih-Ching Lin; Kei Haga; Robert L Atmar; Nils Lycke; Jonas Nilsson; Mary K Estes; Marta Bally; Göran Larson
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

6.  Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression.

Authors:  Jessica Bauer; Gerhard Liebisch; Claudia Hofmann; Christian Huy; Gerd Schmitz; Florian Obermeier; Jürgen Bock
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

Review 7.  Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics.

Authors:  Luca Pastorelli; Carlo De Salvo; Joseph R Mercado; Maurizio Vecchi; Theresa T Pizarro
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561

8.  Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells.

Authors:  Yao Zhang; Rui-Dong Duan
Journal:  Lipids Health Dis       Date:  2009-12-01       Impact factor: 3.876

Review 9.  Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract.

Authors:  Krzysztof Kurek; Bartłomiej Łukaszuk; Dominika M Piotrowska; Patrycja Wiesiołek; Anna Małgorzata Chabowska; Małgorzata Zendzian-Piotrowska
Journal:  Biomed Res Int       Date:  2013-09-05       Impact factor: 3.411

Review 10.  Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces.

Authors:  Loubna Abdel Hadi; Clara Di Vito; Laura Riboni
Journal:  Mediators Inflamm       Date:  2016-01-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.